18,19-Dehydrobuprenorphine
A semi-synthetic opioid derived from buprenorphine
18,19-Dehydrobuprenorphine is a semi-synthetic opioid derived from buprenorphine. It is a potent analgesic and is primarily used in research settings to study opioid receptor interactions.
Chemical structure and properties[edit | edit source]
18,19-Dehydrobuprenorphine is structurally similar to buprenorphine, with the primary difference being the presence of a double bond between the 18 and 19 positions on the molecular structure. This modification can affect the compound's binding affinity and activity at the opioid receptors.
Pharmacology[edit | edit source]
18,19-Dehydrobuprenorphine acts as a partial agonist at the mu-opioid receptor and an antagonist at the kappa-opioid receptor. This dual action is similar to that of buprenorphine, but the presence of the additional double bond may alter its pharmacokinetic and pharmacodynamic properties.
Mechanism of action[edit | edit source]
The compound binds to the mu-opioid receptors in the central nervous system, leading to analgesic effects. Its action as a kappa-opioid receptor antagonist may contribute to its reduced potential for causing dysphoria compared to full kappa agonists.
Clinical significance[edit | edit source]
While 18,19-Dehydrobuprenorphine is not used clinically, its study provides valuable insights into the development of new analgesics with potentially improved safety profiles. Understanding its interaction with opioid receptors can aid in the design of drugs that minimize the risk of opioid addiction and other side effects.
Research applications[edit | edit source]
Research involving 18,19-Dehydrobuprenorphine focuses on its receptor binding characteristics and its potential use as a tool in neuroscience to explore opioid receptor function. It is also used in studies aimed at developing new therapeutic agents for pain management.
Related pages[edit | edit source]
Gallery[edit | edit source]
Chemical structure of 18,19-Dehydrobuprenorphine
18,19-Dehydrobuprenorphine[edit | edit source]
Structure of 18,19-Dehydrobuprenorphine
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
